Biocept, Inc. (NASDAQ: BIOC) Surges 54% After Announcing the Commercial Launch of Target Selector Liquid Biopsy for Lung Cancer
Biocept, Inc. (NASDAQ: BIOC) is engaged as a molecular diagnostics company, which utilizes a proprietary liquid biopsy technology that is ...
